Quantinno Capital Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Quantinno Capital Management's DYN Position: Q3 2026 in Review
Quantinno Capital Management increased its Dyne Therapeutics (DYN) stake by 534% in Q3 2026, buying an estimated $6.32M and bringing the position to 326,646 shares worth $5.26M. The position accounts for 0.01% of the portfolio, ranked #1418.
Quantinno Capital Management first reported a position in DYN in Q3 2025 and has held it in 5 quarters since. 270 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Quantinno Capital Management held 326,646 shares of Dyne Therapeutics worth $5.26M as of Q3 2026.
- Quantinno Capital Management bought 275,157 Dyne Therapeutics shares in Q3 2026, an estimated $6.32M.
- Dyne Therapeutics made up 0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1418 holding.
- Quantinno Capital Management first reported a position in Dyne Therapeutics in Q3 2025 and has held it in 5 quarters since.
- 270 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.